ir.helus.com

Helus Pharma strengthens medical leadership by appointing Dr. Ken to a leadership role. The release focuses on organizational and governance updates, highlighting the new appointee as part of the company’s strategy for its medical and scientific direction. This is an investor-relations style announcement, useful for tracking leadership changes that may affect the company’s future clinical and development priorities.